Debt-to-equity of International Stem Cell CORP from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
International Stem Cell CORP quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • International Stem Cell CORP Debt-to-equity for the quarter ending 30 Sep 2025 was -128%, a 1.6% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

International Stem Cell CORP Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -128% -2% -1.6% 30 Sep 2025
Q2 2025 -127% +2% +1.7% 30 Jun 2025
Q1 2025 -127% +4% +2.8% 31 Mar 2025
Q4 2024 -125% +5% +3.9% 31 Dec 2024
Q3 2024 -126% +2% +1.5% 30 Sep 2024
Q2 2024 -129% -6% -4.7% 30 Jun 2024
Q1 2024 -131% -10% -8.4% 31 Mar 2024
Q4 2023 -130% -9% -7.3% 31 Dec 2023
Q3 2023 -128% -8% -6.5% 30 Sep 2023
Q2 2023 -124% -3% -2.8% 30 Jun 2023
Q1 2023 -121% +1% +0.54% 31 Mar 2023
Q4 2022 -122% +3% +2% 31 Dec 2022
Q3 2022 -120% +6% +4.7% 30 Sep 2022
Q2 2022 -120% +12% +9.2% 30 Jun 2022
Q1 2022 -121% +19% +14% 31 Mar 2022
Q4 2021 -124% +28% +18% 31 Dec 2021
Q3 2021 -126% +41% +25% 30 Sep 2021
Q2 2021 -132% +81% +38% 30 Jun 2021
Q1 2021 -141% +132% +48% 31 Mar 2021
Q4 2020 -152% +202% +57% 31 Dec 2020
Q3 2020 -168% +4518% +96% 30 Sep 2020
Q2 2020 -213% 30 Jun 2020
Q1 2020 -272% 31 Mar 2020
Q4 2019 -354% 31 Dec 2019
Q3 2019 -4686% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.